Serologic methods are becoming increasingly important in the diagnosis of mycotic infections. Necessary prerequisites for the evaluation of such tests should include information on the antigenic relationships of strains within a species as well as relationships with other species, both closely and distantly related.
Several investigations of interspecies cross reactions among fungi have appeared during the past few years Pates, 1948;  Salvin, 1949 Salvin, , 1950 Saslaw and Campbell, 1948;  Tenenberg and Howell, 1948) . The existence of more than one antigenic type within the species Cryptococcus neoformans also has been reported (Evans, 1950) . The possibility of using a serologic test in the diagnosis of cryptococcosis (Neill et al., 1951) suggests a need for further knowledge of the antigenic relationships among cryptococci and other microorganisms, particularly those likely to cause cerebrospinal infection.
The purpose of this paper is to present information on cross reactions occurring among strains of C. neoformans and antigens of other microorganisms and higher forms.
MATERIALS AND METHODS
Immunizing antigen. Four strains of Cryptococcus neoformans were employed for preparing immunizing antigens: RE and 4189 (Type A); 1523 (Type B); and LE (Type C). All strains were plated out repeatedly to secure small capsule variants ; however, complete success was obtained with only the LE and RE strains. The remaining two (1523 and 4189) retained a moderate sized capsule. Each strain was grown in one liter of neopeptone dialysate-glucose medium with constant mechanical agitation at room temperature (Evans and Theriault, 1953) . After 24 hours of incubation, the cells were removed by centrifugation and resuspended in 100 ml of saline containing 1 per cent formalin. These suspensions were placed at 37 C for 12 hours and then adjusted to a concentration 4 X 108 cells per ml by hemocytometer count. The stock vaccines were stored in the cold, and before injection a measured quantity of cellular suspension was centrifuged and resuspended in fresh saline solution.
Antiserum. Rabbits weighing approximately 5 pounds were bled to obtain pre-immunization serum and then injected intravenously on the first 3 days of each week with 1 ml of antigen (4 X 108 cells). Antibodies were demonstrable in most rabbits after 21 to 30 injections (7 to 10 weeks); however, injections were continued for longer periods of time to secure higher titered antisera. Antisera from each bleeding were given a sepaiate number. A partial list of sera, prepared in this study, is given in table 2. Titers for the capsular "quellung"2 reaction are indicated. In most cases, tube agglutination titers are 4 to 8 times as high as the quellung titers.
A "polyvalent" antiserum capable of reacting equally well with types A, B, and C has been prepared by injecting rabbits with a vaccine containing equal numbers of strains RE, 1523, and LE with a total count of 4 X 108 cells per ml. The immunization schedule and dose were E. E. EVANS, L. J. SORENSEN, AND K. W. WALLS the same as those used for the preparation of typing antisera. Since antibodies for each type did not always appear at the same rate, it was found necessary to substitute occasional injections of "monovalent" antigen for the type yielding a low antibody response.
In cross reaction studies, commercially prepared typing sera were employed.
Antigens. Cryptococcus soluble antigens were prepared by growing cultures at room temperature with constant agitation in neopeptone dialysate glucose medium (Evans and Theriault, 1953 Serologic tests. Agglutination and quellung reactions were conducted as in a previous study (Evans, 1950 Commercially prepared histoplasmin, blastomycin, and trichophytin were used in precipitin tests. Coccidioidin used was prepared by the method of Smith et al. (1950) . Also included in cross reaction studies were pneumococcus capsular polysaccharides S1 and read at the end of 2 hours' incubation at room temperature and again after 12 hours of refrigeration.
RESULTS
The specificity of antisera produced in this study is of about the same order as the earlier products (Evans, 1950) . There was some cross reaction between types A, B, and C, but the antigenic differences are marked, even with unabsorbed antiserum. Type B antisera reacted strongly with type A antigen and in one case, serum 9-1523-40 (table 2) (Evans and Kessel, 1951) . Thus, However, a strong reaction was produced in all there appears to be an antigenic relation between fluid from the patient is tested for the presence of soluble antigen using precipitating antibody from immunized rabbits (Neill et al., 1951) . Further tests for specificity are indicated, using spinal fluid from "normal" humans as wN ell as from patients suffering from deep-seated mycoses and neurological disorders which may be confused with cryptococcosis. The cross reaction of cryptococcus type A with pneumococcus S2 and gum tragacanth is of fundamental interest. Possibly further study will clarify the chemical basis for these cross reactions.
The use of polyvalent anticryptococcal serum would appear to be preferable to typing serum for routine diagnostic wroik although typing serum might find application in epidemiologic surveys. The antisera prepared by Neill and Kapros (1950) appear to exhibit more cross reaction than the typing sera prepared in this study. However, the data presented by these authors do not indicate the extent of cross reaction. It is entirely possible that their antisera were similar to our serum no. 8-1523-47 (table 2) which cross reacts with all three types. The different immunization schedule employed by also may be a factor affecting specificity of antiserums although a critical experiment involving large numbers of animals would be necessary to prove this point. The degree of cross reactivity of an antiserum may depend also on individual differences in the animals used as well as on the length of the immunization period. The latter factor would appear to be important in the case of antiserum 8-1523-47 since an earlier bleeding from the same animal (8-1523-39) failed to cross react with type C.
Although C. neoformans is not a dimorphic organism, there appears to be an antigenic difference between organisms from the animal body and from culture, particularly with the type C strain. It seems possible that similar differences may occur with other pathogenic fungi. Lindberg (1950) 
